Total Payments
$1,292
2023 Payments
$22.94
Companies
12
Transactions
59
Medicare Patients
2,698
Medicare Billing
$259,346
Payment Breakdown by Category
Food & Beverage$792.16 (61.3%)
Education$500.30 (38.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $792.16 | 51 | 61.3% |
| Education | $500.30 | 8 | 38.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $562.59 | 16 | $0 (2019) |
| Janssen Biotech, Inc. | $332.32 | 25 | $0 (2018) |
| Janssen Products, LP | $99.00 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $61.90 | 1 | $0 (2018) |
| AbbVie, Inc. | $57.76 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $54.10 | 5 | $0 (2018) |
| PFIZER INC. | $30.75 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $22.94 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.51 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $21.76 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $22.94 | 1 | Merck Sharp & Dohme LLC ($22.94) |
| 2019 | $15.17 | 1 | Astellas Pharma US Inc ($15.17) |
| 2018 | $991.39 | 39 | Astellas Pharma US Inc ($547.42) |
| 2017 | $262.96 | 18 | Janssen Biotech, Inc. ($135.16) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: UROLOGY | ||||||
| 06/14/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Oncology | ||||||
| 05/30/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: Oncology | ||||||
| 05/17/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: Oncology | ||||||
| 05/14/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Oncology | ||||||
| 04/26/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: UROLOGY | ||||||
| 04/19/2018 | Janssen Pharmaceuticals, Inc | Erleada (Drug) | Education | In-kind items and services | $17.18 | General |
| Category: Oncology | ||||||
| 04/18/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 03/20/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Oncology | ||||||
| 02/27/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Oncology | ||||||
| 01/29/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Oncology | ||||||
| 01/29/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: UROLOGY | ||||||
| 01/16/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: UROLOGY | ||||||
| 01/11/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Oncology | ||||||
| 01/10/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 12/07/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Oncology | ||||||
| 11/27/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: Oncology | ||||||
| 11/21/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Oncology | ||||||
| 11/14/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Oncology | ||||||
| 11/09/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Oncology | ||||||
| 11/09/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Oncology | ||||||
| 10/17/2017 | Janssen Pharmaceuticals, Inc | ZYTIGA (Drug) | Education | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 10/17/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Oncology | ||||||
| 10/12/2017 | Janssen Pharmaceuticals, Inc | ZYTIGA (Drug) | Education | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 580 | 655 | $296,359 | $47,257 |
| 2021 | 14 | 1,098 | 1,473 | $585,888 | $119,061 |
| 2020 | 12 | 1,020 | 1,286 | $511,922 | $93,028 |
Total Patients
2,698
Total Services
3,414
Medicare Billing
$259,346
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 155 | $106,795 | $16,672 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 127 | $62,738 | $10,379 | 16.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 30 | 31 | $35,557 | $7,176 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 25 | $24,475 | $4,156 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $20,174 | $3,570 | 17.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 17 | 19 | $21,926 | $2,563 | 11.7% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 24 | 25 | $12,850 | $1,385 | 10.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 68 | 85 | $9,520 | $868.68 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 152 | 166 | $2,324 | $487.74 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 235 | 333 | $158,958 | $38,572 | 24.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 57 | 69 | $79,143 | $16,160 | 20.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 11 | 100 | $75,800 | $15,035 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 154 | 187 | $71,621 | $14,991 | 20.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $43,424 | $9,081 | 20.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 44 | $28,204 | $6,676 | 23.7% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 43 | 44 | $31,020 | $5,837 | 18.8% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2021 | 55 | 62 | $31,868 | $3,543 | 11.1% |
| 52234 | Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope | Office | 2021 | 11 | 11 | $13,706 | $2,691 | 19.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 185 | 234 | $26,208 | $2,411 | 9.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $5,412 | $1,219 | 22.5% |
| 51701 | Insertion of temporary bladder catheter | Office | 2021 | 12 | 24 | $9,840 | $1,113 | 11.3% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 11 | 29 | $6,960 | $950.33 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 215 | 266 | $3,724 | $783.00 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 211 | 285 | $135,979 | $27,225 | 20.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 65 | 72 | $82,584 | $14,402 | 17.4% |
About Dr. Roger Riechers, MD
Dr. Roger Riechers, MD is a Urology healthcare provider based in Hawthorne, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306886973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Riechers, MD has received a total of $1,292 in payments from pharmaceutical and medical device companies, with $22.94 received in 2023. These payments were reported across 59 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($792.16).
As a Medicare-enrolled provider, Riechers has provided services to 2,698 Medicare beneficiaries, totaling 3,414 services with total Medicare billing of $259,346. Data is available for 3 years (2020–2022), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Pediatric Urology
- Location Hawthorne, NY
- Active Since 06/08/2006
- Last Updated 11/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1306886973
Products in Payments
- ZYTIGA (Drug) $300.93
- MYRBETRIQ (Drug) $193.97
- Erleada (Drug) $173.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $61.90
- Androgel (Drug) $43.58
- XTANDI (Drug) $41.39
- BRIDION (Drug) $22.94
- PRADAXA (Drug) $22.51
- OPSUMIT MACITENTAN (Drug) $21.76
- Definity (Drug) $16.22
- Lupron (Drug) $14.18
- XARELTO (Drug) $10.78
- ZIO Patch (Device) $10.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Hawthorne
Sean Fullerton, M.d, M.D
Urology — Payments: $3,254
Urology $3,254
Dr. Nathan Wong, Md, MD
Urology — Payments: $3,058
Urology $3,058
Dr. Andrew Katims, M.d., M.p.h, M.D., M.P.H
Urology — Payments: $1,206
Urology $1,206
Muhammad Choudhury, Md, MD
Urology — Payments: $392.17
Urology $392.17
Daniel Rosen, M.d, M.D
Urology — Payments: $386.23
Urology $386.23
Denton Allman, M.d, M.D
Urology — Payments: $339.59
Urology $339.59